Clincosm LogoSign in Get a demo

hidradenitis suppurativa (hs)

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa (HS) Trial in Lyon (Skin Swab & Skin Biopsies & Blood Sample)

Not yet recruiting
  • Hidradenitis Suppurativa (HS)
  • Skin Swab & Skin Biopsies & Blood Sample
  • Lyon, Rhône, France
    Department of Dermatology-Hôpital Edouard Herriot
Feb 9, 2023

Hidradenitis Suppurativa (HS) Trial (blood sampling)

Not yet recruiting
  • Hidradenitis Suppurativa (HS)
  • blood sampling
  • (no location specified)
Feb 9, 2023

Hidradenitis Suppurativa (HS) Trial in Winston-Salem (methylene blue, gentian violet, and ovine forestomach wound dressings)

Not yet recruiting
  • Hidradenitis Suppurativa (HS)
  • methylene blue, gentian violet, and ovine forestomach wound dressings
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences Dermatology
Jan 31, 2023

Hidradenitis Suppurativa (HS) Trial in Worldwide (Povorcitinib, Placebo)

Recruiting
  • Hidradenitis Suppurativa (HS)
  • Phoenix, Arizona
  • +44 more
Jan 12, 2023

Hidradenitis Suppurativa (HS) Trial (Povorcitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa (HS)
  • (no location specified)
Nov 10, 2022

Hidradenitis Suppurativa (HS) Trial (secukinumab)

Available
  • Hidradenitis Suppurativa (HS)
  • (no location specified)
Oct 20, 2022

Hidradenitis Suppurativa (HS) Trial in Worldwide (Upadacitinib, Placebo Upadacitinib)

Completed
  • Hidradenitis Suppurativa (HS)
  • Phoenix, Arizona
  • +25 more
Mar 22, 2022

Hidradenitis Suppurativa (HS) Trial (adalimumab, )

Completed
Has Results
  • Hidradenitis Suppurativa (HS)
  • adalimumab
  • placebo
  • (no location specified)
Jul 8, 2021

Hidradenitis Suppurativa (HS) Trial (adalimumab, )

Completed
Has Results
  • Hidradenitis Suppurativa (HS)
  • adalimumab
  • placebo
  • (no location specified)
Jul 2, 2021

Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Aabenraa, Herlev, Odense (Primary exposure variable, Other (exploratory)

Completed
  • Autoimmune Diseases
  • +9 more
  • Primary exposure variable
  • Other (exploratory) exposure variables
  • Aabenraa, Denmark
  • +2 more
Jun 30, 2021

Hidradenitis Suppurativa (HS) Trial in Worldwide (IFX-1, Placebo)

Completed
Has Results
  • Hidradenitis Suppurativa (HS)
  • Birmingham, Alabama
  • +40 more
Mar 15, 2021

Adalimumab in Korean Hidradenitis Suppurativa Subjects

Completed
  • Hidradenitis Suppurativa (HS)
    • Daegu, Daegu Gwang Yeogsi, Korea, Republic of
    • +18 more
    Jun 11, 2020

    Hidradenitis Suppurativa (HS) Trial in Worldwide (Placebo, Adalimumab)

    Completed
    Has Results
    • Hidradenitis Suppurativa (HS)
    • Beverly Hills, California
    • +54 more
    May 4, 2020

    Humira Real-life Effectiveness and Impact on HS Burden of

    Completed
    • Hidradenitis Suppurativa (HS)
      • Calgary, Alberta, Canada
      • +21 more
      Apr 30, 2020